Lisata Therapeutics, Inc.
LSTA
$5.03
-$0.01-0.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 100.00K | -- | 70.00K | -- | 1.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 100.00K | -- | 70.00K | -- | 1.00M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 100.00K | -- | 70.00K | -- | 1.00M |
| SG&A Expenses | 2.05M | 2.46M | 2.69M | 3.25M | 3.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.18M | 4.41M | 4.94M | 5.85M | 5.95M |
| Operating Income | -3.08M | -4.41M | -4.87M | -5.85M | -4.95M |
| Income Before Tax | -2.95M | -4.25M | -4.66M | -5.69M | -4.61M |
| Income Tax Expenses | 0.00 | -- | -- | -962.00K | 0.00 |
| Earnings from Continuing Operations | -2.95M | -4.25M | -4.66M | -4.72M | -4.61M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.95M | -4.25M | -4.66M | -4.72M | -4.61M |
| EBIT | -3.08M | -4.41M | -4.87M | -5.85M | -4.95M |
| EBITDA | -3.06M | -4.37M | -4.82M | -5.80M | -4.91M |
| EPS Basic | -0.34 | -0.49 | -0.54 | -0.55 | -0.55 |
| Normalized Basic EPS | -0.21 | -0.30 | -0.34 | -0.41 | -0.34 |
| EPS Diluted | -0.34 | -0.49 | -0.54 | -0.55 | -0.55 |
| Normalized Diluted EPS | -0.21 | -0.30 | -0.34 | -0.41 | -0.34 |
| Average Basic Shares Outstanding | 8.80M | 8.74M | 8.61M | 8.60M | 8.40M |
| Average Diluted Shares Outstanding | 8.80M | 8.74M | 8.61M | 8.60M | 8.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |